Apollo Hospitals Enterprise Limited (BOM:508869)
India
· Delayed Price · Currency is INR 6,920.80
+1.05 (0.02%)
At close: May 13, 2025
BOM:508869 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Operating Revenue | 190,592 | 166,125 | 146,626 | 105,600 | 112,468 | Upgrade
|
| Revenue | 190,592 | 166,125 | 146,626 | 105,600 | 112,468 | Upgrade
|
| Revenue Growth (YoY) | 14.73% | 13.30% | 38.85% | -6.11% | 16.94% | Upgrade
|
| Cost of Revenue | 124,899 | 109,446 | 95,317 | 74,204 | 74,796 | Upgrade
|
| Gross Profit | 65,693 | 56,679 | 51,309 | 31,396 | 37,672 | Upgrade
|
| Selling, General & Admin | 8,104 | 7,829 | 4,669 | 2,635 | 3,348 | Upgrade
|
| Other Operating Expenses | 33,646 | 28,204 | 24,749 | 17,358 | 18,414 | Upgrade
|
| Operating Expenses | 48,620 | 42,187 | 35,425 | 25,724 | 27,959 | Upgrade
|
| Operating Income | 17,073 | 14,492 | 15,884 | 5,672 | 9,713 | Upgrade
|
| Interest Expense | -3,525 | -3,137 | -3,304 | -4,058 | -4,633 | Upgrade
|
| Interest & Investment Income | 429 | 445 | 351 | 218 | 173 | Upgrade
|
| Earnings From Equity Investments | 180 | -432 | 73 | 8 | -31 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 3 | 6 | -41 | -51 | Upgrade
|
| Other Non Operating Income (Expenses) | -729 | -532 | -310 | -250 | -579 | Upgrade
|
| EBT Excluding Unusual Items | 13,428 | 10,839 | 12,700 | 1,549 | 4,592 | Upgrade
|
| Gain (Loss) on Sale of Investments | 374 | 285 | 253 | 89 | 32 | Upgrade
|
| Gain (Loss) on Sale of Assets | -36 | -150 | -40 | -29 | -37 | Upgrade
|
| Other Unusual Items | 39 | 31 | 2,941 | 606 | 1,983 | Upgrade
|
| Pretax Income | 13,805 | 11,005 | 15,854 | 2,215 | 6,570 | Upgrade
|
| Income Tax Expense | 4,455 | 2,562 | 4,770 | 847 | 2,252 | Upgrade
|
| Earnings From Continuing Operations | 9,350 | 8,443 | 11,084 | 1,368 | 4,318 | Upgrade
|
| Minority Interest in Earnings | -364 | -252 | -528 | 136 | 231 | Upgrade
|
| Net Income | 8,986 | 8,191 | 10,556 | 1,504 | 4,549 | Upgrade
|
| Net Income to Common | 8,986 | 8,191 | 10,556 | 1,504 | 4,549 | Upgrade
|
| Net Income Growth | 9.71% | -22.40% | 601.86% | -66.94% | 92.75% | Upgrade
|
| Shares Outstanding (Basic) | 144 | 144 | 144 | 140 | 139 | Upgrade
|
| Shares Outstanding (Diluted) | 144 | 144 | 144 | 140 | 139 | Upgrade
|
| Shares Change (YoY) | - | - | 2.71% | 0.62% | - | Upgrade
|
| EPS (Basic) | 62.50 | 56.97 | 73.42 | 10.74 | 32.70 | Upgrade
|
| EPS (Diluted) | 62.50 | 56.97 | 73.42 | 10.74 | 32.70 | Upgrade
|
| EPS Growth | 9.71% | -22.40% | 583.57% | -67.15% | 92.75% | Upgrade
|
| Free Cash Flow | 7,834 | 2,484 | 10,388 | 9,692 | 7,799 | Upgrade
|
| Free Cash Flow Per Share | 54.48 | 17.28 | 72.25 | 69.23 | 56.06 | Upgrade
|
| Dividend Per Share | 16.000 | 15.000 | 11.750 | 3.000 | 6.000 | Upgrade
|
| Dividend Growth | 6.67% | 27.66% | 291.67% | -50.00% | - | Upgrade
|
| Gross Margin | 34.47% | 34.12% | 34.99% | 29.73% | 33.50% | Upgrade
|
| Operating Margin | 8.96% | 8.72% | 10.83% | 5.37% | 8.64% | Upgrade
|
| Profit Margin | 4.71% | 4.93% | 7.20% | 1.42% | 4.04% | Upgrade
|
| Free Cash Flow Margin | 4.11% | 1.49% | 7.08% | 9.18% | 6.93% | Upgrade
|
| EBITDA | 22,115 | 19,106 | 20,455 | 9,754 | 13,636 | Upgrade
|
| EBITDA Margin | 11.60% | 11.50% | 13.95% | 9.24% | 12.12% | Upgrade
|
| D&A For EBITDA | 5,042 | 4,614 | 4,571 | 4,082 | 3,923 | Upgrade
|
| EBIT | 17,073 | 14,492 | 15,884 | 5,672 | 9,713 | Upgrade
|
| EBIT Margin | 8.96% | 8.72% | 10.83% | 5.37% | 8.64% | Upgrade
|
| Effective Tax Rate | 32.27% | 23.28% | 30.09% | 38.24% | 34.28% | Upgrade
|
| Revenue as Reported | 191,655 | 167,028 | 147,408 | 106,050 | 112,738 | Upgrade
|
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.